Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses-Reference-Cited by-同舟云学术

Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses

Published:2019-06-20 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Herrera-Gómez Francisco^ORCID,Chimeno M. Montserrat,Martín-García Débora,Lizaraso-Soto Frank,Maurtua-Briseño-Meiggs Álvaro,Grande-Villoria Jesús,Bustamante-Munguira Juan,Alamartine Eric,Vilardell Miquel,Ochoa-Sangrador Carlos^ORCID,Álvarez F. Javier^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-45431-5.pdf

Reference65 articles.

1. Stenvinkel, P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J. Intern. Med. 268, 456–467, https://doi.org/10.1111/j.1365-2796.2010.02269.x (2010).

2. Yousuf, O. et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J. Am. Coll. Cardiol. 62, 397–408, https://doi.org/10.1016/j.jacc.2013.05.016 (2013).

3. Formentini, I. et al. Current drug development challenges in chronic kidney disease (CKD)–identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Nephrol. Dial. Transplant. 27, iii81–iii88, https://doi.org/10.1093/ndt/gfs270 (2012).

4. Joshi, S. & Viljoen, A. Renal biomarkers for the prediction of cardiovascular disease. Curr. Opin. Cardiol. 30, 454–460, https://doi.org/10.1097/HCO.0000000000000177 (2015).

5. Zoccali, C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int. 70, 26–33, https://doi.org/10.1038/sj.ki.5000417 (2006).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023;Atherosclerosis Plus;2024-03

2. A clinical case of SARS-CoV-2 infection complicated by nephrogenic pulmonary edema and COVID-associated pneumonitis, alveolitis;Russian Journal of Infection and Immunity;2023-04-01

3. Therapieoptionen bei diabetischer Nephropathie;Die Diabetologie;2023-02-21

4. Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis;Pharmaceutics;2022-12-20

5. Atherosclerosis Specific Features in Chronic Kidney Disease (CKD);Biomedicines;2022-08-27